2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2018 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2015 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 2.999.999 | 400.000 | 1 | ||
2018 | 0 | 3.605.245 | 263.659 | 1 | ||
2015 | 0 | 144.000 | 13.500 | 1 | ||
2012 | 0 | 11.425.095 | 770.800 | 1 |
Total number of partners: 44
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 44
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-01-01 | Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation. | NeutroCure | participant | 2.999.999 | 12 |
2018-01-01 | COmbatting disorders of adaptive immunity with Systems MedICine | COSMIC | participant | 3.605.245 | 18 |
2015-07-01 | Reactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils. | REDOXIT | participant | 144.000 | 4 |
2012-01-01 | NOX enzymes as mediators of inflammation-triggered neurodegeneration: modulating NOX enzymes as novel therapies | NEURINOX | participant | 11.425.095 | 14 |